Log in

NanoVibronix Stock Price, News & Analysis (NASDAQ:NAOV)

0.00 (0.00 %)
(As of 10/16/2019 08:30 AM ET)
Today's Range
Now: $2.99
50-Day Range
MA: $2.60
52-Week Range
Now: $2.99
Volume43 shs
Average Volume8,981 shs
Market Capitalization$13.25 million
P/E RatioN/A
Dividend YieldN/A
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products in the United States, Israel, Europe, India, and internationally through distributor agreements. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Current SymbolNASDAQ:NAOV



Sales & Book Value

Annual Sales$320,000.00
Book Value$0.12 per share


Net Income$-4,150,000.00
Net Margins-1,406.00%


Market Cap$13.25 million
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable

Receive NAOV News and Ratings via Email

Sign-up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter.

NanoVibronix (NASDAQ:NAOV) Frequently Asked Questions

What is NanoVibronix's stock symbol?

NanoVibronix trades on the NASDAQ under the ticker symbol "NAOV."

How were NanoVibronix's earnings last quarter?

NanoVibronix Inc (NASDAQ:NAOV) released its earnings results on Wednesday, August, 14th. The company reported ($0.16) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.20) by $0.04. The business had revenue of $0.26 million for the quarter, compared to the consensus estimate of $0.09 million. NanoVibronix had a negative return on equity of 766.68% and a negative net margin of 1,406.00%. View NanoVibronix's Earnings History.

When is NanoVibronix's next earnings date?

NanoVibronix is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for NanoVibronix.

What is the consensus analysts' recommendation for NanoVibronix?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoVibronix in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NanoVibronix.

Has NanoVibronix been receiving favorable news coverage?

Media headlines about NAOV stock have been trending very negative this week, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. NanoVibronix earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the company's share price in the near term. View News Stories for NanoVibronix.

Are investors shorting NanoVibronix?

NanoVibronix saw a increase in short interest in September. As of September 30th, there was short interest totalling 30,000 shares, an increase of 25.0% from the August 30th total of 24,000 shares. Based on an average trading volume of 14,100 shares, the short-interest ratio is presently 2.1 days. Currently, 0.9% of the company's shares are sold short. View NanoVibronix's Current Options Chain.

Who are some of NanoVibronix's key competitors?

What other stocks do shareholders of NanoVibronix own?

Who are NanoVibronix's key executives?

NanoVibronix's management team includes the folowing people:
  • Mr. Brian M. Murphy, CEO & Director (Age 62)
  • Dr. William Stern, Pres (Age 77)
  • Mr. Stephen R. Brown CPA, Chief Financial Officer (Age 63)
  • Dr. Harold Jacob, Chief Medical Officer & Director (Age 65)
  • Mr. Amir Rippel, VP of Marketing

How do I buy shares of NanoVibronix?

Shares of NAOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is NanoVibronix's stock price today?

One share of NAOV stock can currently be purchased for approximately $2.99.

How big of a company is NanoVibronix?

NanoVibronix has a market capitalization of $13.25 million and generates $320,000.00 in revenue each year. The company earns $-4,150,000.00 in net income (profit) each year or ($0.64) on an earnings per share basis. NanoVibronix employs 10 workers across the globe.View Additional Information About NanoVibronix.

What is NanoVibronix's official website?

The official website for NanoVibronix is http://www.nanovibronix.com/.

How can I contact NanoVibronix?

NanoVibronix's mailing address is 525 Executive Blvd, Elmsford NY, 10523. The company can be reached via phone at 914-233-3004 or via email at [email protected]

MarketBeat Community Rating for NanoVibronix (NASDAQ NAOV)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  96 (Vote Underperform)
Total Votes:  161
MarketBeat's community ratings are surveys of what our community members think about NanoVibronix and other stocks. Vote "Outperform" if you believe NAOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NAOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: 52- Week Highs

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel